Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Rheumatology (Oxford, England)|December 14, 2025
Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registryRossella De Angelis, Clodoveo Ferri, Edoardo Cipolletta, et al.Autoimmunity Reviews|July 31, 2022
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literatureClodoveo Ferri, Rossella De Angelis, Dilia Giuggioli, et al.European Journal of Clinical Investigation|July 4, 2025
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registryAntonio Tonutti, Francesca Motta, Rossella De Angelis, et al.Journal of Translational Autoimmunity|June 29, 2026
The clinical profile of systemic sclerosis without a 'scleroderma pattern' at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of RheumatologyAntonio Tonutti, Maria De Santis, Francesca Motta, et al.Therapeutic Advances in Musculoskeletal Disease|February 9, 2026
Age and onset timing of Raynaud's phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR)Silvia Peretti, Cosimo Bruni, Francesco Bonomi, et al.Scientific Reports|June 2, 2026
Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World StudyAlessandro Conforti, Alarico Ariani, Martina Gentile, et al.Rheumatology and Therapy|March 14, 2026
Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic ArthritisValentino Paci, Alarico Ariani, Eleonora Celletti, et al.Current Pharmaceutical Design|September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing TreatmentsClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.RMD Open|May 13, 2026
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for RheumatologyVeronica Batani, Ilaria Cavazzana, Martina Orlandi, et al.Current Pharmaceutical Design|June 21, 2022
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing TherapiesClodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, et al.Pageof 8